A new biocompatible alloy has been developed, and it’s about 3-4 times harder than most steels and pure titanium.

Crystal structure of beta-Ti3Au (blue – titanium, red – gold). Image credit: Rice University.
Titanium is the leading material for artificial knee and hip joints because it’s strong, wear-resistant and nontoxic.
The new alloy, a 3-to-1 mixture of titanium and gold (Ti3Au), has even better properties.
“It is about 3-4 times harder than most steels. And it’s four times harder than pure titanium, which is what’s currently being used in most dental implants and replacement joints,” said Prof. Emilia Morosan of Rice University in Houston, TX, senior author on a study in the journal Science Advances that describes the properties of the new material.
According to Prof. Morosan and co-authors, making Ti3Au at ‘high temperatures’ produces an almost pure crystalline form of the beta version of Ti3Au (β-Ti3Au) – the crystal structure that’s four times harder than titanium.
At lower temperatures, the atoms tend to arrange in another cubic structure – α-Ti3Au. This structure is about as hard as regular titanium.
“The fourfold increase in the hardness of Ti3Au compared to other Ti–Au alloys and compounds can be attributed to the elevated valence electron density, the reduced bond length, and the pseudogap formation,” the scientists said.
Because titanium and gold by themselves are among the most biocompatible metals and are often used in medical implants, they believed β-Ti3Au would be comparable.
In fact, tests by the team determined that the new alloy was even more biocompatible than pure titanium.
The story proved much the same for wear resistance: β-Ti3Au also outperformed pure titanium.
Prof. Morosan and her colleagues are planning to conduct follow-up tests to further investigate the crystal structure of β-Ti3Au and to see if chemical dopants might improve its hardness even further.
_____
Eteri Svanidze et al. 2016. High hardness in the biocompatible intermetallic compound β-Ti3Au. Science Advances 2 (7): e1600319; doi: 10.1126/sciadv.1600319